July 16, 2026 argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026
June 3, 2026 argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
Follow us
Get the latest news and info via our social media channels.